Ishara Investments LP
Position in ARWR — Arrowhead Pharmaceuticals, Inc.
CIK 2111609
LOS ANGELES, CA
Position in ARWR
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$3,470,445
New position
Shares Held
55,350
first reported quarter
Ownership
0.039%
of shares outstanding
% of Portfolio
3.50%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Position in Biotechnology
Healthcare · as of Mar 31, 2026Ishara Investments LP holds $93,075,669 across 35 Biotechnology names. ARWR ranks #8 (3.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | PRAX |
Praxis Precision Medicines, Inc.
|
22,550 | $7,265,384 | |
| 2 | AXSM |
Axsome Therapeutics, Inc.
|
41,000 | $6,929,820 | |
| 3 | KALV |
KalVista Pharmaceuticals, Inc.
|
276,750 | $5,570,977 | |
| 4 | FOLD |
AMICUS THERAPEUTICS, INC.
|
369,000 | $5,335,740 | |
| 5 | BMRN |
Biomarin Pharmaceutical Inc
|
82,000 | $4,632,180 | |
| 6 | VSTM |
Verastem, Inc.
|
820,000 | $4,346,000 | |
| 7 | RARE |
Ultragenyx Pharmaceutical Inc.
|
174,250 | $3,650,537 | |
| 8 | ARWR |
Arrowhead Pharmaceuticals, Inc.
This page
|
55,350 | $3,470,445 |
All Filings in ARWR
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $3,470,445 | 55,350 | Shares | Sole | 2026-05-15 | |
| No filing history on record for this holder in this stock. | ||||||